Glumakova, K.; Ivanov, G.; Vedernikova, V.; Shyrokova, L.; Lebedev, T.; Stomakhin, A.; Zenchenko, A.; Oslovsky, V.; Drenichev, M.; Prassolov, V.;
et al. Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1. Pharmaceutics 2023, 15, 2389.
https://doi.org/10.3390/pharmaceutics15102389
AMA Style
Glumakova K, Ivanov G, Vedernikova V, Shyrokova L, Lebedev T, Stomakhin A, Zenchenko A, Oslovsky V, Drenichev M, Prassolov V,
et al. Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1. Pharmaceutics. 2023; 15(10):2389.
https://doi.org/10.3390/pharmaceutics15102389
Chicago/Turabian Style
Glumakova, Ksenia, Georgy Ivanov, Valeria Vedernikova, Lena Shyrokova, Timofey Lebedev, Andrei Stomakhin, Anastasia Zenchenko, Vladimir Oslovsky, Mikhail Drenichev, Vladimir Prassolov,
and et al. 2023. "Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1" Pharmaceutics 15, no. 10: 2389.
https://doi.org/10.3390/pharmaceutics15102389
APA Style
Glumakova, K., Ivanov, G., Vedernikova, V., Shyrokova, L., Lebedev, T., Stomakhin, A., Zenchenko, A., Oslovsky, V., Drenichev, M., Prassolov, V., & Spirin, P.
(2023). Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1. Pharmaceutics, 15(10), 2389.
https://doi.org/10.3390/pharmaceutics15102389
